News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Daiichi Sankyo Co Ltd., Eli Lilly and Company (JOBS) Win European Approval for Prasugrel
February 23, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOSTON, Feb 23 (Reuters) - Eli Lilly & Co and Japan's Daiichi Sankyo Co said on Monday that they had won European approval for their blood-thinning drug Efient, also known as prasugrel.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Eli Lilly and Company
Daiichi Sankyo
MORE ON THIS TOPIC
Policy
HHS debuts ‘unprecedented’ initiative to ‘restore American leadership’ in clinical trials
June 22, 2026
·
3 min read
·
Heather McKenzie
FDA
REGENXBIO to resubmit application for Hunter gene therapy after FDA’s most recent pivot
June 22, 2026
·
3 min read
·
Heather McKenzie
FDA
Denali sells FDA voucher for $195M to support neurodegenerative pipeline
June 19, 2026
·
1 min read
·
Annalee Armstrong
Adcomms
Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership
June 19, 2026
·
2 min read
·
Tristan Manalac
